Syndax Pharmaceuticals - Stock Price History | SNDX

Historical daily share price chart and data for Syndax Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Syndax Pharmaceuticals as of September 27, 2021 is 19.76.
  • The all-time high Syndax Pharmaceuticals stock closing price was 26.44 on December 21, 2020.
  • The Syndax Pharmaceuticals 52-week high stock price is 27.85, which is 40.9% above the current share price.
  • The Syndax Pharmaceuticals 52-week low stock price is 13.02, which is 34.1% below the current share price.
  • The average Syndax Pharmaceuticals stock price for the last 52 weeks is 19.53.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Syndax Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 15.1945 8.7700 26.4400 6.6500 22.2400 153.30%
2019 7.3815 4.4500 10.7600 4.2600 8.7800 97.30%
2018 8.2461 8.7700 14.8200 3.6000 4.4500 -49.20%
2017 10.9948 7.3200 14.8600 6.6800 8.7600 22.18%
2016 12.6122 12.0100 17.1300 6.9100 7.1700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.961B $0.002B
Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company's product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage. Syndax Pharmaceuticals, Inc. is based in WALTHAM, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29